Asset Details
Do you wish to reserve the book?
Clinical outcomes of endovascular therapy in acute basilar artery occlusion with low pc-ASPECTS
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Clinical outcomes of endovascular therapy in acute basilar artery occlusion with low pc-ASPECTS
Do you wish to request the book?
Clinical outcomes of endovascular therapy in acute basilar artery occlusion with low pc-ASPECTS
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Clinical outcomes of endovascular therapy in acute basilar artery occlusion with low pc-ASPECTS
2025
Overview
BackgroundThe effectiveness and safety of endovascular therapy (EVT) in patients with Acute Basilar Artery Occlusion (ABAO) with low pc-ASPECTS is unclear.ObjectiveTo evaluate the effectiveness and safety of EVT in ABAO patients with low pc-ASPECTS.MethodsWe analyzed 199 ABAO patients with pc-ASPECTS ≤ 6 who were prospectively registered in the BASILAR study. The patients were divided into the standard medical treatment group (SMT group) and the endovascular therapy group (EVT group). We compared the differences between the two groups in terms of primary outcomes (mRS scores of 0–3, 0–2 and 0–1 at 1 year), secondary outcomes (mRS scores of 0–3, 0–2 and 0–1 at 90 days), primary safety outcomes (symptomatic intracranial haemorrhage at 48 h, mortality at 90 days).ResultsAmong the 199 patients, 134 (67.34%) were in the EVT group. Compared with the SMT group, the EVT group showed a significantly higher likelihood of achieving mRS score of 0–3 [adjusted OR [aOR] 21.17, 95% CI (2.08–215.43), P = 0.010] and mRS score of 0–2 [aOR 16.34, 95% CI (1.64–163.32), P = 0.017] at 1 year. There was no significant difference in safety outcomes at 90 days between the two groups.ConclusionsEVT improves long-term clinical outcomes in ABAO patients with pc-ASPECTS ≤ 6, patients undergoing EVT demonstrated significantly better functional outcomes at 1 year compared to those receiving SMT, with no significant difference in mortality at 90 days. Overall, ABAO patients treated with EVT achieve both effective and safe outcomes.
Publisher
Springer Nature B.V
Subject
